Analysis of Drug Pricing, Healthcare Practices, and Margin Rates in the Market

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The chapter explores the effects of a sole generic competitor on brand name drug prices, shedding light on potential cost decreases. It also covers the regulatory landscape of medical device patents and the FTC's actions against anti-competitive behavior in healthcare, with a spotlight on cases and investigations initiated by the FTC. Furthermore, it discusses Robinhood's competitive low margin rates in contrast to other major brokerages, emphasizing their innovative approach to margin lending.

Episode 356: Neal and Toby dive into the EU’s latest campaign against Big Tech, namely Meta and Apple, alleging these companies are stifling competition in Europe. Then, the Boston Celtics are just coming off an NBA championship, but that doesn’t stop the owners from selling the team. Plus, the FTC is looking into ‘junk’ patents from pharmaceutical companies meant to prevent generic drug makers from cutting into their business. Meanwhile, Roaring Kitty is at it again, this time making movements for Chewy.com. Next, Toby examines the trend of ‘romantasy’ novels that are flying off the shelves. Lastly, China might have a way around high US tariffs: golf carts.

Get your Morning Brew Daily Mug HERE: https://shop.morningbrew.com/products/morning-brew-daily-mug?utm_medium=youtube&utm_source=mbd&utm_campaign=mug

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices